Home » Proposal » Geza benke phd thesis proposal

Geza benke phd thesis proposal

REFERENCES

Cartwright RA. McNally R. Staines A. The growing incidence of non-Hodgkin’s lymphoma (National hockey league): the potential role of sunlight. Leukaemia Lymphoma 1994 14. 387 94.

CrossRef ,
PubMed ,
CAS ,
Web of Science® Occasions Reported: 84

McMichael AJ. Giles GG. Have increases in solar ultraviolet exposure led to the increase in incidence of non-Hodgkin’s lymphoma? Br J Cancer 1996 73. 945 50.

CrossRef ,
PubMed ,
CAS ,
Web of Science® Occasions Reported: 63

Bentham G. Association between incidence of non-Hodgkin’s lymphoma and solar ultraviolet radiation in Britain. Br Mediterranean J 1996 312. 1128 31.

CrossRef ,
PubMed ,
CAS ,
Web of Science® Occasions Reported: 59

Freedman DM. Zahm SH. Dosemeci M. Residential and work-related contact with sunlight and mortality from non-Hodgkin’s lymphoma: composite (threefold) situation-control study. Br Mediterranean J 1997 314. 1451 5.

CrossRef ,
PubMed ,
CAS ,
Web of Science® Occasions Reported: 54

Grant WB. Approximately premature cancer mortality within the U.S. because of insufficient doses of solar ultraviolet-B radiation. Cancer 2002 94. 1867 75.

Hu S. Ma F. Collado-Mesa F. Kirsner RS. Ultraviolet radiation and incidence of non-Hodgkin’s Lymphoma among Hispanics within the U . s . States. Cancer Epidem Biomar 2004 13. 59 64.

CrossRef ,
PubMed ,
CAS ,
Web of Science® Occasions Reported: 31

Hughes AM. Lance armstrong BK. Vajdic C. Turner J. Grulich A. Fritschi L. Milliken S. Kaldor J. Benke G. Kricker A. Pigmentary characteristics, sun-sensitivity and non-Hodgkin lymphoma. Int J Cancer 2004 110. 429 34.

Cooper KD. Oberhelman L. Hamilton TA. Baadsgaard O. Terhune M.

Geza benke phd thesis proposal Phototherapy and

LeVee G. Anderson T. Koren H. Ultra violet exposure reduces immunization rates and promotes ability to tolerate epicutaneous antigens in humans: relationship to dose, CD1a-DR+ epidermal macrophage induction, and Langerhans cell depletion. Proc Natl Acad Sci U S A 1992 89. 8497 501.

CrossRef ,
PubMed ,
CAS ,
Web of Science® Occasions Reported: 242 ,
ADS

Hardell L. Eriksson M. Degerman A. Contact with phenoxyacetic acids, chlorophenols, or organic solvents with regards to histopathology, stage, and physiological localization of non-Hodgkin’s lymphoma. Cancer Res 1994 54. 2386 9.

PubMed ,
CAS ,
Web of Science® Occasions Reported: 78

Adami J. Gridley G. Nyren O. Dosemeci M. Linet M. Glimelius B. Ekbom A. Zahm SH. Sunlight and non-Hodgkin’s lymphoma: a population-based cohort study in Norway. Int J Cancer 1999 80. 641 5.

Hakansson N. Floderus B. Gustavsson P. Feychting M. Hallin N. Work-related sunlight exposure and cancer incidence among Swedish construction workers. Epidemiology 2001 12. 552 7.

CrossRef ,
PubMed ,
CAS ,
Web of Science® Occasions Reported: 49

van Wijngaarden E. Savitz DA. Work-related sunlight exposure and mortality from non-Hodgkin lymphoma among electric utility workers. J Occup Environ Mediterranean 2001 43. 548 53.

CrossRef ,
PubMed ,
CAS ,
Web of Science® Occasions Reported: 12

Tracey E. Supramaniam R. Cancer in Nsw Incidence and mortality 2000 featuring projections to 2010 for selected sites. Sydney. Cancer Council NSW, 2002.

Tracey EA. Supramaniam R.

Geza benke phd thesis proposal Does exposure to UV

Chen W. Cancer in Nsw: incidence and mortality 2001. Sydney. Cancer Council NSW, 2003.

Turner JJ. Hughes AM. Kricker A. Milliken S. Grulich A. Kaldor J. Lance armstrong B. Utilisation of the WHO lymphoma classification inside a population-based epidemiological study. Ann Oncol 2004 15. 631 7.

CrossRef ,
PubMed ,
CAS ,
Web of Science® Occasions Reported: 11

Kricker A. Lance armstrong BK. British DR. Heenan PJ. A serving-response curve for exposure to the sun and basal cell carcinoma. Int J Cancer 1995 60. 482 8.

Vajdic CM. Kricker A. Giblin M. McKenzie J. Aitken J. Giles G. Lance armstrong BK. Exposure to the sun predicts chance of ocular melanoma around australia. Int J Cancer 2002 101. 175 82.

Kricker A. Lance armstrong BK. British DR. Heenan PJ. Does intermittent exposure to the sun cause basal cell carcinoma? a situation-control study in Wa. Int J Cancer 1995 60. 489 94.

British DR. Lance armstrong BK. Kricker A. Reproducibility of reported measurements of exposure to the sun inside a situation-control study. Cancer Epidem Biomar 1998 7. 857 63.

PubMed ,
CAS ,
Web of Science® Occasions Reported: 49

Vajdic, C. M. Exposure to the sun and ocular melanoma around australia. PhD thesis, School of Public Health, College of Sydney, 2001.

Bureau of Meteorology. Laboratory and radiation sub-section solar exposure data 19471998. (Version NCCSOL 2.204, 8 Feb 1999). Melbourne. Bureau of Meteorology, 1999.

Worldwide Research Institute for Climate Conjecture. Columbia College. Worldwide Satellite Cloud Climatology Project: solar radiation and cloudiness. Offered by: ingrid.ldgo.columbia.edu/SOURCES/.ISCCP/.MONTHLY/.solr. 1999.

National Center for Atmospheric Research, Atmospheric Chemistry Division. Tropospheric Ultraviolet and visual Radiation Model, version 4.1. Internet, 2002.

Elwood JM. Diffey BL. Considered of ambient solar ultraviolet radiation within the interpretation of studies from the aetiology of melanoma. Melanoma Res 1993 3. 113 22.

PubMed ,
CAS ,
Web of Science® Occasions Reported: 24

Australian Bureau of Statistics. Socio-Economic Indexes for Areas, Australia. ABS Catalog No. 2039.. ABS Catalog No. 2039.. 2-10- 1998. Commonwealth of Australia, Canberra.

Australian Bureau of Statistics. How Australians use time. ABS Catalog No. 4153.. ABS Catalog No. 4153.. 1998. Commonwealth of Australia, Canberra.

Anderson Junior. Armitage JO. Weisenburger DD. Epidemiology from the non-Hodgkin’s lymphomas: distributions from the major subtypes differ by geographic locations. Non-Hodgkin’s Lymphoma Classification Project. Ann Oncol 1998 9. 717 20.

CrossRef ,
PubMed ,
CAS ,
Web of Science® Occasions Reported: 133

Brownson RC. Reif JS. A cancer registry-based study of work-related risk for lymphoma, multiple myeloma and leukaemia. Int J Epidemiol 1988 17. 27 32.

CrossRef ,
PubMed ,
CAS ,
Web of Science® Occasions Reported: 53

Cantor KP. Farming and mortality from non-Hodgkin’s lymphoma: a situation-control study. Int J Cancer 1982 29. 239 47.

Kelleher C. Newell J. MacDonagh-White-colored C. MacHale E. Egan E. Connolly E. Gough H. Delaney B. Shryane E. Incidence and work-related pattern of leukaemias, lymphomas, and testicular tumours in western Ireland over an 11 year period. J Epidemiol Commun H 1998 52. 651 6.

CrossRef ,
PubMed ,
CAS ,
Web of Science® Occasions Reported: 9

Morison WL. Phototherapy and photochemotherapy of skin condition. New You are able to. Raven Press, 1991.

Forest JS. Polissar L. Severson RK. Heuser LS. Kulander BG. Soft tissue sarcoma and non-Hodgkin’s lymphoma with regards to phenoxyherbicide and chlorinated phenol exposure in western Washington. J Natl Cancer I 1987 78. 899 910.

PubMed ,
CAS ,
Web of Science® Occasions Reported: 171

Ullrich SE. Does contact with Ultra violet radiation induce a shift to some Th-2-like immune reaction? Photochem Photobiol 1996 64. 254 8.

Grulich AE. Wan X. Law MG. Milliken ST. Lewis CR. Garsia RJ. Gold J. Finlayson RJ. Cooper DA. Kaldor JM. B-cell stimulation and prolonged immune deficiency are risks for non-Hodgkin’s lymphoma in individuals with AIDS. AIDS 2000 14. 133 40.

CrossRef ,
PubMed ,
CAS ,
Web of Science® Occasions Reported: 67

Schroeder Junior. Saah AJ. Hoover DR. Margolick JB. Ambinder RF. Martinez-Maza O. Breen EC. Jacobson LP. Variakojis D. Rowe DT. Armenian HK. Serum soluble CD23 level correlates with subsequent growth and development of AIDS-related non-Hodgkin’s lymphoma. Cancer Epidemiol Biomarkers Prev 1999 8. 979 84.

PubMed ,
CAS ,
Web of Science® Occasions Reported: 12

Vineis P. Miligi L. Crosignani P. Fontana A. Masala G. Nanni O. Ramazzotti V. Rodella S. Stagnaro E. Tumino R. Vigano C. Vindigni C. et al. Delayed infection, family size and malignant lymphomas. J Epidemiol Community Health 2000 54. 907 11.

CrossRef ,
PubMed ,
CAS ,
Web of Science® Occasions Reported: 28

Doody MM. Linet MS. Glass AG. Friedman GD. Pottern LM. Boice JD Junior. Fraumeni JF Junior. Leukemia, lymphoma, and multiple myeloma following selected health conditions. Cancer Causes Control 1992 3. 449 56.

CrossRef ,
PubMed ,
CAS ,
Web of Science® Occasions Reported: 59

Tavani A. La Vecchia C. Franceschi S. Serraino D. Carbone A. Health background and chance of Hodgkin’s and non-Hodgkin’s lymphomas. Eur J Cancer Prev. 2000 9. 59 64.

CrossRef ,
PubMed ,
CAS ,
Web of Science® Occasions Reported: 60

Carol EA. Bracci PM. Population-based study of non-hodgkin lymphoma, histology, and health background among hiv-negative participants in Bay Area. Am J Epidemiol 2003 158. 316 27.

CrossRef ,
PubMed ,
Web of Science® Occasions Reported: 46

Hickish T. Cunningham D. Colston K. Millar BC. Sandle J. Mackay AG. Soukop M. Sloane J. The result of just one,25-dihydroxyvitamin D3 on lymphoma cell lines and expression of vitamin D receptor in lymphoma. Br J Cancer 1993 68. 668 72.

CrossRef ,
PubMed ,
CAS ,
Web of Science® Occasions Reported: 23

Majewski S. Skopinska M. Marczak M. Szmurlo A. Bollag W. Jablonska S. Vitamin D3 is really a potent inhibitor of tumor cell-caused angiogenesis. J Investig Dermatol Symp Proc 1996 1. 97 101.

PubMed ,
CAS ,
Web of Science®

Garland CF. Comstock GW. Garland FC. Helsing KJ. Shaw EK. Gorham Erectile dysfunction. Serum 25-hydroxyvitamin D and cancer of the colon: eight-year prospective study. Lancet 1989 2. 1176 8.

CrossRef ,
PubMed ,
CAS ,
Web of Science® Occasions Reported: 273

Ahonen MH. Tenkanen L. Teppo L. Hakama M. Tuohimaa P. Cancer of the prostate risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland). Cancer Cause Control 2000 11. 847 52.

CrossRef ,
PubMed ,
CAS ,
Web of Science® Occasions Reported: 166

Levine AJ. Harper JM. Ervin CM. Chen YN. Harmon E. Xue S. Lee ER. Frankel HD. Haile RW. Serum 25-hydroxyvitamin D, nutritional calcium intake, and distal colorectal adenoma risk. Nutr Cancer 2001 39. 35 41.

CrossRef ,
PubMed ,
CAS ,
Web of Science® Occasions Reported: 32

Tuohimaa P. Tenkanen L. Ahonen M. Lumme S. Jellum E. Hallmans G. Stattin P. Harvei S. Hakulinen T. Luostarinen T. Dillner J. Lehtinen M. et al. Both everywhere amounts of bloodstream vitamin D are connected having a greater cancer of the prostate risk: a longitudinal, nested situation-control study within the Nordic countries. Int J Cancer 2004 108. 104 8.

Freedman DM. Dosemeci M. McGlynn K. Sunlight and mortality from breast, ovarian, colon, prostate, and non-melanoma cancer of the skin: an amalgamated dying certificate based situation-control study. Occup Environ Mediterranean 2002 59. 257 62.

CrossRef ,
PubMed ,
CAS ,
Web of Science® Occasions Reported: 133

Bodiwala D. Luscombe CJ. French ME. Liu S. Saxby MF. Johnson PW. Ramachandran S. Fryer AA. Strange RC. Inclination towards cancer of the prostate: studies on interactions between UVR exposure and type of skin. Carcinogenesis 2003 24. 711 7.

CrossRef ,
PubMed ,
CAS ,
Web of Science® Occasions Reported: 22

DeLuca HF. Zierold C. Mechanisms and processes of vitamin D. Nutr Rev 1998 56. S4 10.

Boonstra A. Barrat FJ. Crain C. Heath VL. Savelkoul HF. O’Garra A. 1alpha,25-Dihydroxyvitamin d3 has an effect on naive CD4(+) T cells to boost the introduction of Th2 cells. J Immunol. 2001 167. 4974 80.